Prevalence and factors associated with adherence to Highly Active Antiretroviral Treatment at the Specialist Hospital Yola, Adamawa State, Nigeria

Submitted: October 9, 2023
Accepted: February 19, 2024
Published: June 21, 2024
Abstract Views: 46
PDF: 32
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.


Adherence to Highly Active Antiretroviral Therapy (HAART) medication is an important predictor of a successful treatment and improvement of quality of life among People Living with Human Immunodeficiency Virus (HIV) / Acquired Immunodeficiency Syndrome (AIDS) (PLWHA). In the seven years before this study, several measures were taken to improve adherence to HAART among PLWHA at the study site, but no work has been published to establish the impact of the measures. We conducted a cross-sectional study among HIV-positive patients attending the antiretroviral clinic of State Specialist Hospital Yola, Adamawa State, Nigeria, in October-December 2019. Adherence was measured using self-report and was defined as taking at least ≥95% of the prescribed doses of Antiretroviral Therapy (ART) in the seven days preceding the survey. A total of 431 PLWHA participated in the study. There was an 88.4% adherence rate, and forgetfulness (62.2%) was the most common reason for missing HAART dosages. Adherence was found to be 92.1% (p=0.017) among those who have been on HAART for ˃2 years, 92.3% (p=0.01) among those not afraid of stigma, and 92.9% (p=0.002) among those who practice Islamic faith. Other factors associated with higher adherence included age less than 34 years, 91.2% (p=0.167), income of ˂₦30,000 per month, 88.6% (p=0.858), and less educated, 90.5% (p=0.852). The study showed adherence prevalence was 88.4%. Forgetfulness was found to be the most common reason for missing HAART dosages. We therefore recommend the introduction of medication adherence reminders into the HIV programs.



PlumX Metrics


Download data is not yet available.


Cobucci RNO, Lima PH, Souza PC de, et al. Assessing the impact of HAART on the incidence of defining and non-defining AIDS cancers among patients with HIV/AIDS: a systematic review. Journal of Infection and Public Health 2015;8:1-10. DOI:
Yaya I, Landoh DE, Saka B, et al. Predictors of adherence to antiretroviral therapy among People Living with HIV and AIDS at the regional hospital of Sokodé, Togo. BMC Public Health 2014;14:1308. DOI:
Olowookere SA, Fatiregun AA, Akinyemi JO, et al. Prevalence and determinants of nonadherence to Highly Active Antiretroviral Therapy among People Living with HIV/AIDS in Ibadan, Nigeria. J Infect Dev Ctries 2008;2:369-72. DOI:
Fielden SJ, Rusch MLA, Yip B, et al. Nonadherence increases the risk of hospitalization among HIV-infected antiretroviral naive patients started on HAART. J Int Assoc Physicians AIDS Care (Chic) 2008;7:238-44. DOI:
Abdulsamad H, Oche OM, Raji MO, Mohammed Y. Prevalence and factors associated with treatment adherence among patients on Highly Active Antiretroviral Therapy (HAART) in Specialist Hospital, Sokoto, Nigeria. International Archives of Medical and Health Research 2019;1:7.
Ekstrand ML, Shet A, Chandy S, et al. Suboptimal adherence associated with virological failure and resistance mutations to first line Highly Active Antiretroviral Therapy (HAART) in Bangalore, India. Int Health 2011;3:27-34. DOI:
Salami AK, Fadeyi A, Ogunmodede JA, Desalu O. Factors influencing adherence to antiretroviral medication in Ilorin, Nigeria. J Int Assoc Physicians AIDS Care (Chic) 2010;9:191-5. DOI:
Mills EJ, Nachega JB, Bangsberg DR, et al. Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Medicine 2006;3:2039-64. DOI:
Li L, Lee SJ, Wen Y, et al. Antiretroviral Therapy adherence among patients living with HIV/AIDS in Thailand. Nurs Health Sci 2010;12:212-20. DOI:
Vermund SH. Massive benefits of Antiretroviral Therapy in Africa. Journal of Infectious Diseases 2014;209:483-5. DOI:
Abebe KB, Tegegne AS. Predictors of non-adherence to medication and time to default from treatment on HIV infected patients under HAART: a comparison of joint and separate models. Afr Health Sci 2022;22:443-55. DOI:
Cadosch D, Bonhoeffer S, Kouyos R. Assessing the impact of adherence to Anti-Retroviral Therapy on treatment failure and resistance evolution in HIV. J R Soc Interface 2012;9:2309-20. DOI:
Yu Y, Luo D, Chen X, et al. Medication adherence to Antiretroviral Therapy among newly treated People Living with HIV. BMC Public Health 2018;18:825. DOI:
Cochran WG. Sampling techniques. 3rd ed. John Wiley & Sons; New York, USA; 1977.
Hansana V, Sanchaisuriya P, Durham J, et al. Adherence to Antiretroviral Therapy (ART) among People Living with HIV (PLHIV): a cross-sectional survey to measure in Lao PDR. BMC Public Health 2013;13:617. DOI:
Addo MK, Aboagye RG, Tarkang EE. Factors influencing adherence to antiretroviral therapy among HIV/AIDS patients in the Ga West Municipality, Ghana. IJID Reg 2022;3:218-25. DOI:
Maqutu D, Zewotir T, North D, et al. Determinants of optimal adherence over time to Antiretroviral Therapy amongst HIV positive adults in South Africa: a longitudinal study. AIDS Behav 2011;15:1465-74. DOI:
Chime OH, Ndibuagu EO, Orji CJ. Rates and predictors of adherence and retention for Antiretroviral Therapy among HIV-positive adults in Enugu, Nigeria. Malawi Med J 2019;31:202-11. DOI:
Hutahaean BSH, Stutterheim SE, Jonas KJ. Barriers and facilitators to HIV treatment adherence in Indonesia: perspectives of People Living with HIV and HIV service providers. Trop Med Infect Dis 2023;8:138. DOI:
Buh A, Deonandan R, Gomes J, et al. Prevalence and factors associated with HIV treatment non-adherence among people living with HIV in three regions of Cameroon: a cross-sectional study. PLoS One 2023;18:e0283991. DOI:
Aung S, Hardy N, Chrysanthopoulou SA, et al. Stigma determines antiretroviral adherence in adults with HIV in Myanmar. J Acquir Immune Defic Syndr 2022;89:19-26. DOI:
Morowatisharifabad MA, Movahed E, Farokhzadian J, et al. antiretroviral therapy adherence based on information, motivation, and behavioral skills model and its association with depression among HIV-positive patients: health promotion strategy towards the 909090 target. J Educ Health Promot 2019;8:192. DOI:
Tsega B, Srikanth BA, Shewamene Z. Determinants of non-adherence to Antiretroviral Therapy in adult hospitalized patients, Northwest Ethiopia. Patient Prefer Adherence 2015;9:373-80. DOI:
Crim SM, Tie Y, Beer L, et al. Barriers to Antiretroviral Therapy adherence among HIV-positive Hispanic and Latino men who have sex with men - United States, 2015-2019. MMWR Morb Mortal Wkly Rep 2020;69:1437-42. DOI:
Maduka O, Tobin-West CI. Adherence counseling and reminder text messages improve uptake of Antiretroviral Therapy in a tertiary hospital in Nigeria. Niger J Clin Pract 2013;16:302-8. DOI:
Ibeneme SC, Ndukwu SC, Myezwa H, et al. Effectiveness of mobile text reminder in improving adherence to medication, physical exercise, and quality of life in patients living with HIV: a systematic review. BMC Infectious Diseases 2021;21:859. DOI:

How to Cite

Stephen, R. I., Rimande , J., Obadiah, M. A., Awang, S. K., Dunga, J. A., Bulundi, I., & Atinge, S. (2024). Prevalence and factors associated with adherence to Highly Active Antiretroviral Treatment at the Specialist Hospital Yola, Adamawa State, Nigeria. Annals of African Medical Research, 7(1).